Click for best price
DTaP Tdap Vaccines Market Size, Share 2022
Market Analysis and Insights: Global DTaP Tdap Vaccines Market
The global DTaP Tdap Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DTaP Tdap Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DTaP Tdap Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DTaP Tdap Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DTaP Tdap Vaccines market.
Global DTaP Tdap Vaccines Scope and Market Size
DTaP and Tdap Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global DTaP and Tdap Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the DTaP and Tdap Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
DTaP
Td
Tdap
Segment by Application
Adult
Pediatric
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes DTaP Tdap Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of DTaP Tdap Vaccines, with price, sales, revenue, and global market share of DTaP Tdap Vaccines from 2019 to 2022.
Chapter 3, the DTaP Tdap Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTaP Tdap Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the DTaP Tdap Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of DTaP Tdap Vaccines.
Chapter 13, 14, and 15, to describe DTaP Tdap Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 DTaP Tdap Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States DTaP and Tdap Vaccines Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 DTaP and Tdap Vaccines Product Introduction
1.2 Global DTaP and Tdap Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global DTaP and Tdap Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global DTaP and Tdap Vaccines Sales in Volume for the Year 2017-2028
1.3 United States DTaP and Tdap Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States DTaP and Tdap Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States DTaP and Tdap Vaccines Sales in Volume for the Year 2017-2028
1.4 DTaP and Tdap Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States DTaP and Tdap Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of DTaP and Tdap Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 DTaP and Tdap Vaccines Market Dynamics
1.5.1 DTaP and Tdap Vaccines Industry Trends
1.5.2 DTaP and Tdap Vaccines Market Drivers
1.5.3 DTaP and Tdap Vaccines Market Challenges
1.5.4 DTaP and Tdap Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 DTaP and Tdap Vaccines Market Segment by Type
2.1.1 DTaP
2.1.2 Td
2.1.3 Tdap
2.2 Global DTaP and Tdap Vaccines Market Size by Type
2.2.1 Global DTaP and Tdap Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global DTaP and Tdap Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States DTaP and Tdap Vaccines Market Size by Type
2.3.1 United States DTaP and Tdap Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States DTaP and Tdap Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 DTaP and Tdap Vaccines Market Segment by Application
3.1.1 Adult
3.1.2 Pediatric
3.2 Global DTaP and Tdap Vaccines Market Size by Application
3.2.1 Global DTaP and Tdap Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global DTaP and Tdap Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global DTaP and Tdap Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States DTaP and Tdap Vaccines Market Size by Application
3.3.1 United States DTaP and Tdap Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States DTaP and Tdap Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States DTaP and Tdap Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global DTaP and Tdap Vaccines Competitor Landscape by Company
4.1 Global DTaP and Tdap Vaccines Market Size by Company
4.1.1 Top Global DTaP and Tdap Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global DTaP and Tdap Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global DTaP and Tdap Vaccines Price by Manufacturer (2017-2022)
4.2 Global DTaP and Tdap Vaccines Concentration Ratio (CR)
4.2.1 DTaP and Tdap Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of DTaP and Tdap Vaccines in 2021
4.2.3 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global DTaP and Tdap Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers DTaP and Tdap Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States DTaP and Tdap Vaccines Market Size by Company
4.5.1 Top DTaP and Tdap Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States DTaP and Tdap Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States DTaP and Tdap Vaccines Sales by Players (2020, 2021 & 2022)
5 Global DTaP and Tdap Vaccines Market Size by Region
5.1 Global DTaP and Tdap Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global DTaP and Tdap Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global DTaP and Tdap Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global DTaP and Tdap Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global DTaP and Tdap Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global DTaP and Tdap Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global DTaP and Tdap Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific DTaP and Tdap Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporation Information
7.1.2 Sanofi Pasteur Description and Business Overview
7.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
7.1.5 Sanofi Pasteur Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporation Information
7.2.2 GlaxoSmithKline Description and Business Overview
7.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
7.2.5 GlaxoSmithKline Recent Development
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Corporation Information
7.3.2 Protein Sciences Corporation Description and Business Overview
7.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
7.3.5 Protein Sciences Corporation Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Corporation Information
7.4.2 Novartis AG Description and Business Overview
7.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
7.4.5 Novartis AG Recent Development
7.5 Seqirus
7.5.1 Seqirus Corporation Information
7.5.2 Seqirus Description and Business Overview
7.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
7.5.5 Seqirus Recent Development
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Corporation Information
7.6.2 Merck Sharp & Dohme Corp Description and Business Overview
7.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
7.6.5 Merck Sharp & Dohme Corp Recent Development
7.7 Astellas Pharma US, Inc
7.7.1 Astellas Pharma US, Inc Corporation Information
7.7.2 Astellas Pharma US, Inc Description and Business Overview
7.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
7.7.5 Astellas Pharma US, Inc Recent Development
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporation Information
7.8.2 Pfizer Inc Description and Business Overview
7.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
7.8.5 Pfizer Inc Recent Development
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporation Information
7.9.2 Johnson & Johnson Description and Business Overview
7.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
7.9.5 Johnson & Johnson Recent Development
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
7.11 AstraZeneca
7.11.1 AstraZeneca Corporation Information
7.11.2 AstraZeneca Description and Business Overview
7.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 AstraZeneca DTaP and Tdap Vaccines Products Offered
7.11.5 AstraZeneca Recent Development
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Corporation Information
7.12.2 Emergent BioSolutions Inc Description and Business Overview
7.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Emergent BioSolutions Inc Products Offered
7.12.5 Emergent BioSolutions Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 DTaP and Tdap Vaccines Industry Chain Analysis
8.2 DTaP and Tdap Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 DTaP and Tdap Vaccines Distributors
8.3 DTaP and Tdap Vaccines Production Mode & Process
8.4 DTaP and Tdap Vaccines Sales and Marketing
8.4.1 DTaP and Tdap Vaccines Sales Channels
8.4.2 DTaP and Tdap Vaccines Distributors
8.5 DTaP and Tdap Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. DTaP and Tdap Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. DTaP and Tdap Vaccines Market Trends
Table 3. DTaP and Tdap Vaccines Market Drivers
Table 4. DTaP and Tdap Vaccines Market Challenges
Table 5. DTaP and Tdap Vaccines Market Restraints
Table 6. Global DTaP and Tdap Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States DTaP and Tdap Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global DTaP and Tdap Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States DTaP and Tdap Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top DTaP and Tdap Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global DTaP and Tdap Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global DTaP and Tdap Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global DTaP and Tdap Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global DTaP and Tdap Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global DTaP and Tdap Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DTaP and Tdap Vaccines as of 2021)
Table 18. Top Players of DTaP and Tdap Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers DTaP and Tdap Vaccines Product Type
Table 20. Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top DTaP and Tdap Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States DTaP and Tdap Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States DTaP and Tdap Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States DTaP and Tdap Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States DTaP and Tdap Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global DTaP and Tdap Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global DTaP and Tdap Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global DTaP and Tdap Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global DTaP and Tdap Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global DTaP and Tdap Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America DTaP and Tdap Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific DTaP and Tdap Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific DTaP and Tdap Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe DTaP and Tdap Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa DTaP and Tdap Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa DTaP and Tdap Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Sanofi Pasteur Corporation Information
Table 43. Sanofi Pasteur Description and Business Overview
Table 44. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Sanofi Pasteur DTaP and Tdap Vaccines Product
Table 46. Sanofi Pasteur Recent Development
Table 47. GlaxoSmithKline Corporation Information
Table 48. GlaxoSmithKline Description and Business Overview
Table 49. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. GlaxoSmithKline Product
Table 51. GlaxoSmithKline Recent Development
Table 52. Protein Sciences Corporation Corporation Information
Table 53. Protein Sciences Corporation Description and Business Overview
Table 54. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Protein Sciences Corporation Product
Table 56. Protein Sciences Corporation Recent Development
Table 57. Novartis AG Corporation Information
Table 58. Novartis AG Description and Business Overview
Table 59. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Novartis AG Product
Table 61. Novartis AG Recent Development
Table 62. Seqirus Corporation Information
Table 63. Seqirus Description and Business Overview
Table 64. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Seqirus Product
Table 66. Seqirus Recent Development
Table 67. Merck Sharp & Dohme Corp Corporation Information
Table 68. Merck Sharp & Dohme Corp Description and Business Overview
Table 69. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Merck Sharp & Dohme Corp Product
Table 71. Merck Sharp & Dohme Corp Recent Development
Table 72. Astellas Pharma US, Inc Corporation Information
Table 73. Astellas Pharma US, Inc Description and Business Overview
Table 74. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Astellas Pharma US, Inc Product
Table 76. Astellas Pharma US, Inc Recent Development
Table 77. Pfizer Inc Corporation Information
Table 78. Pfizer Inc Description and Business Overview
Table 79. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Pfizer Inc Product
Table 81. Pfizer Inc Recent Development
Table 82. Johnson & Johnson Corporation Information
Table 83. Johnson & Johnson Description and Business Overview
Table 84. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Johnson & Johnson Product
Table 86. Johnson & Johnson Recent Development
Table 87. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 88. Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table 89. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Lanzhou Institute of Biological Products Co., Ltd Product
Table 91. Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table 92. AstraZeneca Corporation Information
Table 93. AstraZeneca Description and Business Overview
Table 94. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. AstraZeneca Product
Table 96. AstraZeneca Recent Development
Table 97. Emergent BioSolutions Inc Corporation Information
Table 98. Emergent BioSolutions Inc Description and Business Overview
Table 99. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Emergent BioSolutions Inc Product
Table 101. Emergent BioSolutions Inc Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. DTaP and Tdap Vaccines Customers List
Table 105. DTaP and Tdap Vaccines Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. DTaP and Tdap Vaccines Product Picture
Figure 2. Global DTaP and Tdap Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global DTaP and Tdap Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global DTaP and Tdap Vaccines Sales 2017-2028 (K Units)
Figure 5. United States DTaP and Tdap Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States DTaP and Tdap Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States DTaP and Tdap Vaccines Sales 2017-2028 (K Units)
Figure 8. United States DTaP and Tdap Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States DTaP and Tdap Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. DTaP and Tdap Vaccines Report Years Considered
Figure 11. Product Picture of DTaP
Figure 12. Product Picture of Td
Figure 13. Product Picture of Tdap
Figure 14. Global DTaP and Tdap Vaccines Market Share by Type in 2022 & 2028
Figure 15. Global DTaP and Tdap Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global DTaP and Tdap Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 17. Global DTaP and Tdap Vaccines Sales by Type (2017-2028) & (K Units)
Figure 18. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global DTaP and Tdap Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States DTaP and Tdap Vaccines Market Share by Type in 2022 & 2028
Figure 21. United States DTaP and Tdap Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States DTaP and Tdap Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 23. United States DTaP and Tdap Vaccines Sales by Type (2017-2028) & (K Units)
Figure 24. United States DTaP and Tdap Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States DTaP and Tdap Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Adult
Figure 27. Product Picture of Pediatric
Figure 28. Global DTaP and Tdap Vaccines Market Share by Application in 2022 & 2028
Figure 29. Global DTaP and Tdap Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global DTaP and Tdap Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 31. Global DTaP and Tdap Vaccines Sales by Application (2017-2028) & (K Units)
Figure 32. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global DTaP and Tdap Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States DTaP and Tdap Vaccines Market Share by Application in 2022 & 2028
Figure 35. United States DTaP and Tdap Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States DTaP and Tdap Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 37. United States DTaP and Tdap Vaccines Sales by Application (2017-2028) & (K Units)
Figure 38. United States DTaP and Tdap Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States DTaP and Tdap Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America DTaP and Tdap Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America DTaP and Tdap Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe DTaP and Tdap Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe DTaP and Tdap Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific DTaP and Tdap Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific DTaP and Tdap Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America DTaP and Tdap Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America DTaP and Tdap Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa DTaP and Tdap Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa DTaP and Tdap Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE DTaP and Tdap Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. DTaP and Tdap Vaccines Value Chain
Figure 74. DTaP and Tdap Vaccines Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
